All In MedTech

FDA Clearance Tracker · P930016-S059

iDESIGN Refractive Studio and STAR S4 IR Excimer Laser Systems

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 28, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 28, 2019

Approved

Time to decision

60 days

Received Mar 29, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P930016-S059
Device name
iDESIGN Refractive Studio and STAR S4 IR Excimer Laser Systems
Applicant location
Milpitas, CA
Received
Mar 29, 2019
Decided
May 28, 2019
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P930016

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code LZS

FDA's approval statement

As written in FDA's record.

Approval of the revised protocol for the post-approval study (PAS) protocol.

Source documents

Other decisions for Amo Manufacturing USA, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.